Analyst firms · Citigroup · NVRO
Citigroup NVRO price target and rating history
Nevro Corp. (NVRO) · Health Care
Citigroup rates Nevro Corp. (NVRO) Neutral with a $9 price target, as of its latest action on Aug 9, 2024. It has published 5 rating actions on NVRO since August 2021, including 2 upgrades and 3 downgrades.
- Current rating
- Neutral
- Price target
- $9
- Median target, all firms
- Too few
- Actions on NVRO
- 5
Citigroup price target on NVRO
Every Citigroup rating on NVRO
- Aug 9, 2024
- May 22, 2024
- Jan 17, 2023
- May 5, 2022
- Aug 5, 2021
Questions about Citigroup and NVRO
- What is Citigroup's price target for NVRO?
- Citigroup's latest stated price target for Nevro Corp. (NVRO) is $9, from its action on May 22, 2024.
- What is Citigroup's rating on NVRO?
- Citigroup rates NVRO Neutral, a neutral rating, as of Aug 9, 2024.
- When did Citigroup last change its view on NVRO?
- On Aug 9, 2024, Citigroup upgrades to Neutral from Sell.
More NVRO rating histories
- Piper Sandler5
- Wells Fargo8
- Morgan Stanley4
- Canaccord Genuity4
- Robert W. Baird4
- Truist Securities3
- Leerink Partners3
All Citigroup ratingsNVRO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.